Cargando…

Reply to “Treatment considerations for patients with pemphigus during the COVID-19 pandemic”

Detalles Bibliográficos
Autores principales:	Schultz, Brittney, Pearson, David R., Mansh, Matthew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Mosby 2021
Materias:	JAAD Online
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473340/ https://www.ncbi.nlm.nih.gov/pubmed/32896595 http://dx.doi.org/10.1016/j.jaad.2020.07.132

Ejemplares similares

Authors' reply to the comment “Treatment considerations for patients with pemphigus during the COVID-19 pandemic”
por: Shakshouk, Hadir, et al.
Publicado: (2021)

Treatment considerations for patients with pemphigus during the COVID-19 pandemic
por: Shakshouk, Hadir, et al.
Publicado: (2020)

Adalimumab for treatment of hidradenitis suppurativa during the COVID-19 pandemic: Safety considerations
por: Blaszczak, Alecia, et al.
Publicado: (2020)

Reply to Letter to the Editor Regarding: “Applying to dermatology residency during the COVID-19 pandemic”
por: Kearns, Donovan G., et al.
Publicado: (2021)

Toward a COVID-19 vaccine strategy for patients with pemphigus on rituximab
por: Waldman, Reid A., et al.
Publicado: (2021)

Importance of nose wires in face masks: A reply to “Diagnostic and management considerations for “maskne” in the era of COVID-19”
por: Kassamali, Bina, et al.
Publicado: (2021)

Reply to: “Biologics for psoriasis during COVID-19 outbreak”
por: Murrell, Dedee F., et al.
Publicado: (2020)

Reply to: Comments on “Proposed approach for reusing surgical masks in COVID-19 pandemic”
por: Liu, Yuangang, et al.
Publicado: (2020)

Considerations for dermatology residency applicants underrepresented in medicine amid the COVID-19 pandemic
por: Jones, Virginia A., et al.
Publicado: (2020)

Reply to: “Reply: A dermatologic manifestation of COVID-19: Transient livedo reticularis”
por: Manalo, Iviensan F., et al.
Publicado: (2020)

Reply: Potential role of Janus kinase inhibitors in COVID-19
por: Napolitano, Maddalena, et al.
Publicado: (2020)

Reply to: “A dermatologic manifestation of COVID-19: Transient livedo reticularis”
por: Thomas, Cristina
Publicado: (2020)

Reply to: “Comment on ‘Androgenetic alopecia present in the majority of patients hospitalized with COVID-19’”
por: Wambier, Carlos G.
Publicado: (2021)

Reply to early-onset effluvium secondary to COVID-19 and body hair effluvium
por: Wambier, Carlos Gustavo, et al.
Publicado: (2022)

Reply to: “Various forms of skin rash in COVID-19: Petechial rash in a patient with COVID-19 infection”
por: Joob, Beuy, et al.
Publicado: (2020)

Expansion of asynchronous teledermatology during the COVID-19 pandemic
por: Su, Mack Y., et al.
Publicado: (2020)

Recommendations on dermatologic surgery during the COVID-19 pandemic
por: Der Sarkissian, Samuel Antranig, et al.
Publicado: (2020)

Reply: Calm before the storm: Understanding the role of Janus kinase inhibitors in COVID-19
por: Peterson, Danielle, et al.
Publicado: (2020)

Reply to: “COVID-19 vaccination in IMID patients receiving rituximab: A personalized regimen should be formulated”
por: Pahalyants, Vartan, et al.
Publicado: (2022)

Response to: “Successful implementation of phototherapy guidelines during the COVID-19 pandemic”
por: Lim, Henry W., et al.
Publicado: (2021)

Response to: “Applying to dermatology residency during the COVID-19 pandemic”
por: Alia, Erisa, et al.
Publicado: (2021)

Optimizing education for dermatology residents during the COVID-19 pandemic
por: Patel, Parth, et al.
Publicado: (2020)

Modifications to dermatology residency education during the COVID-19 pandemic
por: Mufti, Asfandyar, et al.
Publicado: (2020)

COVID-19: Should sexual practices be discouraged during the pandemic?
por: Yin, ZhiQiang
Publicado: (2020)

Successful implementation of phototherapy guidelines during the COVID-19 pandemic
por: Dragan, Emma, et al.
Publicado: (2021)

Reply to: “COVID-19, syphilis, and biologic therapies for psoriasis and psoriatic arthritis: A word of caution”
por: Lebwohl, Mark, et al.
Publicado: (2020)

Reply to: “Characterization of acute acro-ischemic lesions in non-hospitalized patients: A case series of 132 patients during the COVID-19 outbreak”
por: Ruggiero, Giuseppe, et al.
Publicado: (2020)

Maintaining patient involvement in dermatology education during the COVID-19 pandemic: Challenges and solutions
por: Shi, Connie R., et al.
Publicado: (2022)

Optimizing care for atopic dermatitis patients during the COVID-19 pandemic
por: Shah, Monica, et al.
Publicado: (2020)

Rational hand hygiene during the coronavirus 2019 (COVID-19) pandemic
por: Cavanagh, Gregory, et al.
Publicado: (2020)

Cling film for mobile phones to prevent cross-infection during the COVID-19 pandemic
por: Sethy, Mitanjali, et al.
Publicado: (2020)

Reply to research letter
por: Rivera-Oyola, Ryan, et al.
Publicado: (2020)

Recommendations for medical student preparedness and equity for dermatology residency applications during the COVID-19 pandemic
por: Stewart, Claire R., et al.
Publicado: (2020)

Reply to letter to the editor: “A response to ‘Male balding is a major risk factor for severe COVID-19’”
por: Yousaf, Ahmed, et al.
Publicado: (2021)

Assessing the risk of adalimumab use for hidradenitis suppurativa during the COVID-19 pandemic
por: Kearns, Donovan G., et al.
Publicado: (2020)

Strategies for effective medical student education in dermatology during the COVID-19 pandemic
por: Ashrafzadeh, Sepideh, et al.
Publicado: (2021)

Assessing the risk of dupilumab use for atopic dermatitis during the COVID-19 pandemic
por: Kearns, Donovan G., et al.
Publicado: (2020)

Remote learning for medical student-level dermatology during the COVID-19 pandemic
por: Patel, Payal M., et al.
Publicado: (2020)

Hidradenitis suppurativa: The importance of virtual outpatient care during COVID-19 pandemic
por: Shah, Monica, et al.
Publicado: (2020)

Optimizing teledermatology visits for dermatology resident education during the COVID-19 pandemic
por: Oldenburg, Reid, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ibiu76dnk58am9qasam3fh2vo4